Atraumatic bilateral scapular spine fracture several months after bilateral reverse total shoulder arthroplasty

We report an 89-year-old woman with bilateral atraumatic scapular spine fracture several months after bilateral reverse total shoulder arthroplasty (RTSA). Recently, RTSA has gained popularity in the surgical treatment of complex shoulder disorders such as cuff tear arthropathy. However, scapular fractures may occur several months after surgery as a late complication of this procedure. In this case report we focus on a relatively uncommon subtype, the scapular spine fracture. Although well-known in the orthopedic literature, radiologists are less familiar with this complication. To the best of our knowledge, bilateral scapular fractures have not yet been reported.     

Future directions in personality,occupational and medical selection: myths,misunderstandings, measurement,and suggestions

This paper has two objectives: (1) presenting recent advances in personality theory whereby personality traits are conceptualized within a framework that focuses on the dynamic interactions of behaviour, biology, context, and states, and (2) discussing the implications of these developments for measurement and medical selection. We start by presenting evidence that traits are no longer regarded as stable deterministic predictors of behaviour. Instead, traits are found to change across generations, the life span, and in response to environmental contingencies. Thus, there is an urgent need to explore how traits change as function of medical education. Second, drawing on recent theory and research (behavioural reaction norms and the density distribution model) we highlight evidence to show how the expression of trait relevant behaviour is dependent on context, and is distributed with an average (typical behaviour or personality) and a variance (plasticity or adaptability), with traditional personality measure associated with typical responding. Third, we demystify that some traits are better than others showing that so-called “good” traits have a dark-side. Fourth, we show how these developments impact on how personality might be assessed, thereby presenting recent evidence on the use of contextualized personality measures, situational judgment tests, other reports, and implicit measures. Throughout the paper, we outline the key implications of these developments for medical selection practices.     

Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up.

BACKGROUND & AIMS: Collagenous colitis (CC) is a well-described entity causing chronic diarrhea and characteristic histologic findings. Several treatment options have been suggested, but no controlled data are available. We conducted a placebo-controlled trial to show the clinical and histologic effects of budesonide in CC. METHODS: Twenty-eight patients were randomly assigned to receive placebo (n = 14) or budesonide 9 mg daily (n = 14) for 8 weeks. Patients were evaluated clinically, and blinded biopsy specimens were analyzed from fixed locations at weeks 0 and 8. Clinical response was defined as a decrease of at least 50% in the disease activity score (number of bowel movements in the last 7 days). At week 8, nonresponders received open-label budesonide for the next 8-week period; responders discontinued treatment and were followed up. RESULTS: Three patients discontinued the study prematurely. Intention-to-treat analysis showed clinical response in 8 of 14 patients in the budesonide group compared with 3 of 14 responders for placebo (P = 0.05) after 8 weeks of blinded therapy, together with improved stool consistency. Histologically, there was no change in the mean thickness of the collagen band but a significant decrease of the lamina propria infiltrate in the budesonide group (P < 0.001). CONCLUSIONS: Budesonide is efficacious in inducing short-term clinical response in CC with significant reduction of the histologic infiltrate in the lamina propria.     

Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity: biologic and clinical implications in autoimmune arthritis

OBJECTIVE: To analyze the clinical and biologic correlates of autoantibody induction during longer-term tumor necrosis factor alpha (TNFalpha) blockade with either the monoclonal antibody infliximab or the soluble receptor etanercept. METHODS: Thirty-four patients with spondylarthropathy (SpA) and 59 patients with rheumatoid arthritis (RA) were treated with infliximab for 2 years. Additionally, 20 patients with SpA were treated with etanercept for 1 year. Sera were blindly analyzed for antinuclear antibodies (ANAs), anti-double-stranded DNA (anti-dsDNA) antibodies, anti-extractable nuclear antigen (anti-ENA) antibodies, and antihistone, anti-nucleosome, and anticardiolipin antibodies (aCL). The anti-dsDNA antibodies were isotyped. RESULTS: High numbers of infliximab-treated patients with SpA or RA had newly induced ANAs (61.8% and 40.7%, respectively) and anti-dsDNA antibodies (70.6% and 49.2%, respectively) after 1 year, but no further increase between year 1 and year 2 was observed. In contrast, induction of ANAs and anti-dsDNA antibodies was observed only occasionally in the etanercept-treated patients with SpA (10% of patients each). Isotyping revealed almost exclusively IgM or IgM/IgA anti-dsDNA antibodies, which disappeared upon interruption of treatment. Neither infliximab nor etanercept induced other lupus-related reactivities such as anti-ENA antibodies, antihistone antibodies, or anti-nucleosome antibodies, and no clinically relevant lupus-like symptoms were observed. Similarly, infliximab but not etanercept selectively increased IgM but not IgG aCL titers. CONCLUSION: The prominent ANA and anti-dsDNA autoantibody response is not a pure class effect of TNFalpha blockers, is largely restricted to short-term IgM responses, and is not associated with other serologic or clinical signs of lupus. Similar findings with aCL suggest that modulation of humoral immunity may be a more general feature of infliximab treatment.     

Muscle-Activation Onset Times With Shoes and Foot Orthoses in Participants With Chronic Ankle Instability

Context

Participants with chronic ankle instability (CAI) use an altered neuromuscular strategy to shift weight from double-legged to single-legged stance. Shoes and foot orthoses may influence these muscle-activation patterns.

Objective

To evaluate the influence of shoes and foot orthoses on onset times of lower extremity muscle activity in participants with CAI during the transition from double-legged to single-legged stance.

Design

Cross-sectional study.

Setting

Musculoskeletal laboratory.

Patients or Other Participants

A total of 15 people (9 men, 6 women; age = 21.8 ± 3.0 years, height = 177.7 ± 9.6 cm, mass = 72.0 ± 14.6 kg) who had CAI and wore foot orthoses were recruited.

Intervention(s)

A transition task from double-legged to single-legged stance was performed with eyes open and with eyes closed. Both limbs were tested in 4 experimental conditions: (1) barefoot (BF), (2) shoes only, (3) shoes with standard foot orthoses, and (4) shoes with custom foot orthoses (SCFO).

Main Outcome Measure(s)

The onset of activity of 9 lower extremity muscles was recorded using surface electromyography and a single force plate.

Results

Based on a full-factorial (condition, region, limb, vision) linear model for repeated measures, we found a condition effect (F_3,91.8 = 9.39, P < .001). Differences among experimental conditions did not depend on limb or vision condition. Based on a 2-way (condition, muscle) linear model within each region (ankle, knee, hip), earlier muscle-activation onset times were observed in the SCFO than in the BF condition for the peroneus longus (P < .001), tibialis anterior (P = .003), vastus medialis obliquus (P = .04), and vastus lateralis (P = .005). Furthermore, the peroneus longus was activated earlier in the shoes-only (P = .02) and shoes-with-standard-foot-orthoses (P = .03) conditions than in the BF condition. No differences were observed for the hip muscles.

Conclusions

Earlier onset of muscle activity was most apparent in the SCFO condition for ankle and knee muscles but not for hip muscles during the transition from double-legged to single-legged stance. These findings might help clinicians understand how shoes and foot orthoses can influence neuromuscular control in participants with CAI.Key Words: footwear, insoles, ankle sprains, neuromuscular system, electromyography

Key Points

• Shoes and foot orthoses accelerated muscle-activation onset times of the ankle and knee but not the hip in participants with chronic ankle instability.
• Earlier muscle-activation onset times were most prominent in the shoes-with-custom-foot-orthoses condition.
• At the ankle, the muscle-activation onset time of the peroneus longus was earlier in the shoes-only, shoes-with-standard-foot-orthoses, and shoes-with-custom-foot-orthoses conditions than in the barefoot condition, and the muscle-activation onset time of the tibialis anterior was earlier in the shoes-with-custom-foot-orthoses condition than in the barefoot condition.
• At the knee, the muscle-activation onset times of the vastus medialis obliquus and vastus lateralis were earlier in the shoes-with-custom-foot-orthoses condition than in the barefoot condition.
• The results may help clinicians understand how shoes and foot orthoses can influence neuromuscular control of the lower extremity in participants with chronic ankle instability.

Lateral ankle sprains are estimated to account for approximately 15% of all sport injuries.¹ Even more concerning than the initial ankle sprain is the large proportion of patients with residual symptoms and recurrent ankle sprains for months to years after the initial injury.² The occurrence of repetitive ankle sprains and the feeling of the ankle “giving way” with slight or no perturbation has been defined as chronic ankle instability (CAI).³The transition task from double-legged to single-legged stance during barefoot (BF) conditions has been shown to discriminate between uninjured participants and participants with CAI. Researchers have reported that muscle-activation onset times typically were delayed^4,5 and postural stability was impaired⁶ in participants with CAI, indicating the use of another strategy to shift weight from double-legged to single-legged stance. However, it is unclear whether findings from BF tests represent typical daily situations when shoes, and for some persons foot orthoses, are often worn.The human foot is the first point of contact between the body and a supporting surface. The cutaneous mechanoreceptors on the planar surface of the foot are an important source of sensory information,⁷ which is considered essential for achieving and maintaining functional joint stability.⁸ Shoes and foot orthoses act as an interface between the body and a supporting surface and can influence the sensory feedback from these mechanoreceptors by increasing the contact area between the foot and the supporting surface.^7,9 Furthermore, the small kinematic alterations of the rear foot and tibia that have been described with the use of shoes and foot orthoses¹⁰ may put the ankle joint in a more neutral position, thereby improving the capacity of the ankle mechanoreceptors to provide more accurate proprioceptive input toward the central nervous system.¹¹ Changing the sensory input to these mechanisms consequently would change the motor output.⁷Evidence is increasing that shoes and foot orthoses can influence lower extremity muscle activation.^10,12–14 Dingenen et al¹⁴ were the first investigators to measure the influence of shoes and foot orthoses on muscle-activation onset times of the entire lower extremity in uninjured participants during the transition from double-legged to single-legged stance. Their results showed that shoes and foot orthoses can accelerate muscle-activation onset times of the peroneus longus. No differences were reported in more proximal muscles. Recently, researchers have suggested that future investigators should be focused on the influence of shoes and foot orthoses on neuromuscular control, especially in participants with injuries, such as CAI,^10,13,14 to increase our understanding of how positive clinical outcomes from the use of shoes and foot orthoses can be achieved.¹¹ Altering or improving proprioceptive information and muscle-activation patterns in participants with CAI would be clinically beneficial, given that their proprioceptive and neuromuscular deficits have been described.¹⁵To our knowledge, no investigators have focused on the influence of shoes and foot orthoses on muscle-activation onset times of the entire lower extremity in participants with CAI during the transition from double-legged to single-legged stance. Therefore, the purpose of our study was to evaluate the influence of shoes and foot orthoses on muscle-activation onset times during the transition from double-legged to single-legged stance in participants with CAI. Based on the proposed effects of shoes and foot orthoses on lower extremity neuromuscular control, we hypothesized that shoes and foot orthoses would accelerate muscle-activation onset times compared with a BF condition.     

Fully-automated left ventricular mass and volume MRI analysis in the UK Biobank population cohort: evaluation of initial results

UK Biobank, a large cohort study, plans to acquire 100,000 cardiac MRI studies by 2020. Although fully-automated left ventricular (LV) analysis was performed in the original acquisition, this was not designed for unsupervised incorporation into epidemiological studies. We sought to evaluate automated LV mass and volume (Siemens syngo InlineVF versions D13A and E11C), against manual analysis in a substantial sub-cohort of UK Biobank participants. Eight readers from two centers, trained to give consistent results, manually analyzed 4874 UK Biobank cases for LV end-diastolic volume (EDV), end-systolic volume (ESV), stroke volume (SV), ejection fraction (EF) and LV mass (LVM). Agreement between manual and InlineVF automated analyses were evaluated using Bland–Altman analysis and the intra-class correlation coefficient (ICC). Tenfold cross-validation was used to establish a linear regression calibration between manual and InlineVF results. InlineVF D13A returned results in 4423 cases, whereas InlineVF E11C returned results in 4775 cases and also reported LVM. Rapid visual assessment of the E11C results found 178 cases (3.7%) with grossly misplaced contours or landmarks. In the remaining 4597 cases, LV function showed good agreement: ESV ?6.4?±?9.0 ml, 0.853 (mean?±?SD of the differences, ICC) EDV ?3.0?±?11.6 ml, 0.937; SV 3.4?±?9.8 ml, 0.855; and EF 3.5?±?5.1%, 0.586. Although LV mass was consistently overestimated (29.9?±?17.0 g, 0.534) due to larger epicardial contours on all slices, linear regression could be used to correct the bias and improve accuracy. Automated InlineVF results can be used for case-control studies in UK Biobank, provided visual quality control and linear bias correction are performed. Improvements between InlineVF D13A and InlineVF E11C show the field is rapidly advancing, with further improvements expected in the near future.     

Ankylosing spondylitis and bowel disease

Clinical studies indicate an important role for bowel inflammation in ankylosing spondylitis and other spondyloarthropathies whereby two different aspects have to be considered. First, the gut inflammation is clinically and histologically closely related to Crohn's disease. Recent data on subclinical immune alterations confirm this relationship and suggest that spondyloarthropathy is a unique human model for studying early Crohn's disease. Second, bowel and peripheral joint inflammation are clinically, histologically and pathogenetically linked. The most important clinical implication of these observations is that targeted therapies for Crohn's disease could also be effective for intestinal as well as extra-intestinal disease manifestations in spondyloarthropathy, as evidenced by the recent studies on TNF-alpha blockade. Unravelling the gut-synovium axis in spondyloarthopathy could also contribute to the identification of new therapeutic targets. Finally, assessment of subclinical gut inflammation by histology, serology and genetics could contribute to the stratification of individual patients in subgroups with an optimal response to specific therapeutic interventions.